Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in Denmark compared with PPV23

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae

(2022) Thomas Chandler et al.   Microorganisms

The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy

(2021) Lindsay R. Grant et al.   Expert Review of Vaccines

Health economic evaluation of introducing a PPSV23-based vaccination programme to adults aged 65 and above, and an extension to the 60-64 age group in Denmark

(2021) Anders Muusfeldt Birck et al.   Expert Review of Vaccines

Effectiveness of Pneumococcal Vaccination Against Hospitalized Pneumococcal Pneumonia in Older Adults: A Prospective, Test-Negative Study

(2021) Jung Yeon Heo et al.   JOURNAL OF INFECTIOUS DISEASES

A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age

(2021) Nicola P. Klein et al.   VACCINE

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

(2021) Brandon Essink et al.   CLINICAL INFECTIOUS DISEASES

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination

(2021) Kevin Cannon et al.   VACCINE

Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study

(2020) Michael Asger Andersen et al.   CLINICAL INFECTIOUS DISEASES

A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large cps Fragment from an Oral Streptococcus

(2020) Feroze Ganaie et al.   mBio

A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population

(2020) Jacob Dag Berild et al.   Pathogens

Experimental Human Pneumococcal Colonisation in Older Adults is Feasible and Safe, Not Immunogenic

(2020) Hugh Adler et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study

(2020) Hannah Lawrence et al.   PLOS MEDICINE

Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study

(2019) Jong Hun Kim et al.   VACCINE

Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density

(2019) E.L. German et al.   VACCINE

Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: A Two-Stage Bayesian Meta-Analysis of Observational and RCT Reports

(2018) Hamid Latifi-Navid et al.   Scientific Reports

Impact of the 13-valent pneumococcal conjugate vaccine on incidence of all-cause pneumonia in adults aged ≥ 60 years – a population-based retrospective cohort study

(2018) Martin Kolditz et al.   CLINICAL INFECTIOUS DISEASES

The immunological mechanisms that control pneumococcal carriage

(2017) Simon P. Jochems et al.   PLoS Pathogens

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis

(2017) Gerhard Falkenhorst et al.   PLoS One

Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

(2017) Myint Tin Tin Htar et al.   PLoS One

First Human Challenge Testing of a Pneumococcal Vaccine. Double-Blind Randomized Controlled Trial

(2015) Andrea M. Collins et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

(2015) Marie-Josée J. Mangen et al.   EUROPEAN RESPIRATORY JOURNAL

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

(2015) Marc J.M. Bonten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rethinking Risk for Pneumococcal Disease in Adults: The Role of Risk Stacking

(2015) Stephen I. Pelton et al.   Open Forum Infectious Diseases

Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality

(2014) Zitta Barrella Harboe et al.   CLINICAL INFECTIOUS DISEASES

Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions

(2014) Kimberly M. Shea et al.   Open Forum Infectious Diseases

Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines

(2013) Thomas Benfield et al.   PLoS One

Understanding the burden of pneumococcal disease in adults

(2012) F. Blasi et al.   CLINICAL MICROBIOLOGY AND INFECTION

The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England

(2012) Albert Jan van Hoek et al.   JOURNAL OF INFECTION

Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells

(2012) Elizabeth A. Clutterbuck et al.   JOURNAL OF INFECTIOUS DISEASES

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales

(2012) Nick J. Andrews et al.   VACCINE

Using Health State Utility Values from the General Population to Approximate Baselines in Decision Analytic Models when Condition-Specific Data are Not Available

(2011) Roberta Ara et al.   VALUE IN HEALTH

Clinical and economic burden of community-acquired pneumonia among adults in Europe

(2010) T Welte et al.   THORAX

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species

(2008) Mathias W. Pletz et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS